Walgreens' Private Equity Owner Plans to Double Pharmacy Chain's Profits.

The article focuses on Sycamore Partners, a New York-based private equity firm that acquired Walgreens in a $10 billion deal and aims to double the pharmacy chain's earnings before interest, taxes, depreciation, and amortization (EBITDA) to $4 billion from about $2 billion in 2024. Sycamore has implemented cost-cutting measures and expanded product offerings to improve profitability, while Walgreens is also exploring new revenue streams such as lottery ticket sales. The firm presented its financial targets to shareholders and employees, with options to exit or retain the investment based on performance. Walgreens, previously publicly traded as Walgreens Boots Alliance Inc., has faced challenges from competition and reimbursement pressures, similar to other major drugstore chains. [Extracted from the article]